Observation on the therapeutic effect of intravenous bloodletting combined with low molecular weight heparin in the treatment of chronic pulmonary heart disease and hyperviscosity in plateau area
- VernacularTitle:静脉放血联合低分子肝素治疗高原地区慢性肺源性心脏病高黏血症患者疗效观察
- Author:
Baoyi MA
1
Author Information
1. 甘肃省临夏回族自治州人民医院呼吸科
- Keywords:
Hyperviscosity;
Chronic pulmonary heart disease;
Intravenous bloodletting;
Low molecular weight heparin
- From:
China Modern Doctor
2018;56(14):79-81
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the therapeutic effect of intravenous bloodletting combined with low molecular weight heparin in the treatment of chronic pulmonary heart disease and hyperviscosity in plateau area. Methods 84 patients with chronic pulmonary heart disease complicated with hyperviscosity from plateau area were randomly divided into the control group (40 patients) and the observation group (44 patients). In the two groups, on the basis of routine treatment (anti-infection, anti -asthma, oxygen inhalation, and correction of heart failure), the observation group was further given intravenous bloodletting combined with low molecular weight heparin calcium. The changes of respiratory rate, content of venous hemoglobin, hematocrit and arterial partial pressure of oxygen before and after treatment were monitored and statistically analyzed. Results After treatment, the respiratory rate, content of hemoglobin, hematocrit and PaO2 in the observation group were significantly better than those in the control group (P＜0. 0l). Conclusion Intra-venous bloodletting combined with low molecular weight heparin is more effective than conventional treatment method in the treatment of chronic pulmonary heart disease and hyperviscosity in plateau area.
